Abstract:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a highly contagious and dangerous virus that caused the global COVID-19 pandemic in early 2020. It primarily affects the respiratory system, leading to severe illness and high rates of mortality worldwide. The virus enters the body by binding to a receptor called ACE2, which is present in specific cells of the lungs known as type 2 alveolar epithelial cells. Numerous studies have investigated the consequences of SARS-CoV-2 infection, revealing various impacts on the body. This review provides an overview of SARS-CoV-2, including its structure and how it infects cells. It also examines the different variants of concern, such as Alpha, Beta, Gamma, Delta, and the more recent Omicron variant, discussing their characteristics and the level of damage they cause. The usage of drugs to treat COVID-19 is another aspect that has been covered and compares the effectiveness and use of antiviral drugs in the treatment and its potential benefits in COVID-19 treatment. Furthermore, this review explores the consequences and abnormalities associated with SARS-CoV-2 infection, including its impact on various organs and systems in the body. And also discussing the different COVID-19 vaccines available and their effectiveness in preventing infection and reducing the severity of illness. The current review ensures the recent update of the COVID research with expert's knowledge, collection of numerous data from reliable sources and methodologies as well as update of findings based on reviews. This review also provided clear contextual explanations to aid the interpretation and application of the results. The main motto and limitation of this manuscript are to address the computational methods of drug discovery against the rapidly evolving SARS-CoV-2 virus, which has been discussed. Additionally, current computational approaches which are cost effective and can able to predict the therapeutic agents for the treatment against the virus have also been discussed.

Advancements in the Development of Anti-SARS-CoV-2 Therapeutics

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Clinical development of antivirals against SARS-CoV-2 and its variants

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development

Development of SARS-CoV-2 Entry Antivirals

Current state-of-the-art and potential future therapeutic drugs against COVID-19

Updated Approaches against SARS-CoV-2

Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives

SARS-CoV-2 Cell Entry and Targeted Antiviral Development

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

COVID-19 Variants and Vaccine Development

COVID-19 drug discovery and treatment options

Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances to Counter the SARS-CoV-2 Omicron Variant

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines